Announcement on Voluntary Disclosure of Receiving Drug Clinical Trial Approval Notice for BL-M14D1 for Injection (DLL3 ADC) in Combination Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment